Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danyang Liu

Showing results (141-150 of 143) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 143 results.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 2, 2022
Current apparent treatment-resistant hypertension in patients undergoing peritoneal dialysis: A multi-center cross-sectional studyDan Li, Zhihao Huo, Danyang Liu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 4, 2018
OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 miceChunling Yuan, Xiaoli Guo, Qifan Zhou, et al.
Nature Communications|September 9, 2025
Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndromeJieqing Fan, Danyang Liu, Zhu Ming, et al.
Pageof 15

Showing results (141-150 of 143) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 143 results.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 2, 2022
Current apparent treatment-resistant hypertension in patients undergoing peritoneal dialysis: A multi-center cross-sectional studyDan Li, Zhihao Huo, Danyang Liu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 4, 2018
OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 miceChunling Yuan, Xiaoli Guo, Qifan Zhou, et al.
Nature Communications|September 9, 2025
Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndromeJieqing Fan, Danyang Liu, Zhu Ming, et al.
Pageof 15